Study on the turnover of the receptor for the third component of complement on human lymphoid cells.
The in vitro turnover of the receptor for the third component of complement (C3) was studied in normal peripheral blood lymphocytes (PBL) and in lymphoblastoid cells from established cell cultures of both "normal" and "malignant" origin. The turnover was evaluated by studying i) the disappearance rate of the C3-receptor in cells in which the protein synthesis was blocked by cycloheximide and puromycin, ii) the reexpression rate of the C3-receptor after treatment of the cells with either rabbit antiserum against B lymphocytes or mouse C activated through the alternative pathway by inulin. The results show that the C3-receptor of all the lymphoid cells has roughly a half-life of about 3 to 4 hr. However, the cultured lymphoblastoid cells were less sensitive than normal PBL to inhibition by cycloheximide and showed a faster reexpression rate of the C3-receptor. A spontaneous release of the receptor was found to occur, since a receptor-like activity was detected in the spent culture medium of long-term cultured lymphoid cells.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001402:B-Lymphocytes / Q000276:immunology; D001665:Binding Sites; D003176:Complement C3 / Q000378:metabolism*; D003470:Culture Media; D003513:Cycloheximide / Q000494:pharmacology; D006801:Humans; D007444:Inulin / Q000494:pharmacology; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D011817:Rabbits; D012397:Rosette Formation
D000961:Antilymphocyte Serum; D003176:Complement C3; D003470:Culture Media; D011691:Puromycin; D007444:Inulin; D003513:Cycloheximide